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http:WHAT THIS PAPER ADDS
This study provides details of the performance of bridging stent grafts used in fenestrated and branched
endografting for the treatment of thoracoabdominal aortic aneurysm. It may help in planning the procedure and
in addressing future device developments.Objective/Background: Bridging stent grafts (BSGs) are used to connect the target vessel with the main body
during fenestrated or branched aortic endografting (f/bEVAR). No dedicated devices are available for BSG. The
aims of this study were to assess the performance of BSGs.
Methods: Between January 2004 and May 2014 the data of patients treated with f/bEVAR were prospectively
collected. Only patients treated after January 2010 were included. The main measurement outcome was any BSG
related complications. A logistic regression analysis, including target vessel type, type of joint (fenestration or
cuff), and type of BSG identiﬁed potential risk factors.
Results: One hundred and ﬁfty consecutive patients underwent f/bEVAR, and 523 target vessels were involved.
These included 104 celiac, 140 superior mesenteric, 275 renal, and four other arteries. The technical success rate
was 99% (520/523 target vessels). Balloon expandable BSGs were mainly used (n ¼ 494; 95%), and in 336 (65%)
relining stents were combined. The primary reasons for technical failure were the dislocation of the main body
(n ¼ 1) and unsuccessful cannulation (n ¼ 2). One was revascularized by means of the periscope technique. Four
target vessel injuries were recorded and four renal arteries occluded peri-operatively. After a median follow up of
14 months (interquartile range 5.5e23.0), 13 (2%) BSGs occluded and 19 (4%) required re-interventions. Two
SMA occlusions occurred, leading to death in both patients. The patency and freedom from re-intervention rates
at 3 years amounted to 85% and 91%, respectively. Use of a branched main body was the only independent
risk factor for re-intervention and for the composite event (hazard ratio [HR] 3.5, 95% conﬁdence interval [CI]
1.3e9.9 [p ¼ .02]; and HR 2.8, 95% CI 1.2e7.0 [p < .01], respectively). Of note, the use of relining stents seemed
not to prevent BSG related complications.
Conclusion: The currently used BSGs had low occlusion and re-intervention rates. Modiﬁcations of the branched
design or dedicated BSG devices may improve outcome, especially after bEVAR.
 2015 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
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//dx.doi.org/10.1016/j.ejvs.2015.03.023The safety, feasibility, and effectiveness of these devices
have been demonstrated in different reports, and >7,000
patients worldwide have been treated.2
In general, a modular strategy is used to connect different
devices with an aortic main body (AMB). This is characterized
by a dedicated region working as junction point. The most
extensive experience has been with a single main body plat-
form (Cook Medical, Brisbane, Australia); however, recently,
two other companies have produced devices e the Fenes-
trated Anaconda (Vascutek, Paisley, Scotland) and the
Ventana Fenestrated System (Endologix, Irvine, CA, USA).3,4
Over the last 15 years evolution of the AMB has taken
place. First came fenestrations with different diameters,
with or without nitinol ring structures, and then came
Performance of Bridging Stent Grafts 61helical and axial branches, directed up or downward, and
internally or externally placed.
Moreover, to overcome the necessity of AMB custom-
ization, an off the shelf device, able to ﬁt different anato-
mies, has recently been presented.5
Self and balloon expandable stent grafts have been used to
connect the AMB with the visceral vessels. They work as a
bridge (bridging stent graft [BSG]) between the AMB and the
target visceral vessel. The modular device resulting from AMB
and BSGs has to exclude the aneurysmwhile preserving organ
perfusion. The system requires a degree of ﬂexibility in order
to follow physiological movement and any vessel modiﬁcation
related to aortic elongation or aneurysm shrinkage.
At present, no studies are available comparing the per-
formance of all the different options. To inform the debate,
this article provides details on the performance of BSGs,
analyzing possible risk factors leading to adverse events.
MATERIAL AND METHODS
Between January 2004 and May 2014, based on prospec-
tively collected data, all medical records of patients
suffering from thoracoabdominal (TAAAs) or pararenal
aortic aneurysms (PAAs), and treated by means of a
fenestrated or multi-branched endograft (f/bEVAR), were
reviewed. Only patients treated after January 2010 were
included in this study.Devices
The BSGs for the AMB may be suited to branches or fen-
estrations, or both. Proximal to the AMB, a thoracic
endograft can be used, and distally either an abdominal
tube or a bifurcated endograft with or without iliac side
branch devices.
In all cases, the AMB was based on the Zenith stent graft
platform (Cook Medical), suitable for each patient’s anat-
omy. Details of the planning of custom made f/bEVAR have
been described extensively elsewhere.6,7
In all patients, a dedicated workstation (Aquarius iNtui-
tion; TeraRecon Inc., Foster City, CA, USA) was used for the
planning of the custom made AMB. The planning was
further tested and conﬁrmed by a company sponsored
dedicated core laboratory; manufacturing time took
approximately 8e10 weeks.
The AMB was usually customized using three different
options tomaintain the perfusion of the reno-visceral arteries:
(i) normal or double wide scallop; (ii) small and large nitinol
reinforced fenestration; (iii) straight caudally or cranially
directed cuff or spiral cuff. The latter two options work as the
joint point between the AMB and the BSG. They ensure an
adequate sealing zone and stability between different devices.
Scallops are intended to preserve vessel perfusion with
aneurysm exclusion without the use of further devices.
Thus, this option was excluded from analysis.
The number of joints per AMB depended on the aneurysm
type and the number of target vessels. The combination of
fenestrations and branches in the same AMB was favored in
narrow or angulated reno-visceral aortic segments.The target vessels consisted of celiac trunk (CT), superior
mesenteric artery (SMA), left and right renal arteries (LRA
and RRA, respectively) and, rarely large accessory renal ar-
teries or separate origins of the CT branches. Pre-operative
ostial stenosis and/or dissection of the target vessel were
grouped together and deﬁned as a “challenging target
vessel”.
In November 2012, an off the shelf multi-branched
endograft (t-branch model; Cook Medical),5 characterized
by four caudally directed branches in a standard position,
was introduced.8 It was used according the instruction for
use and not off label.
Appendix 1 provides an overview of the different balloon
or self expandable BSGs used alone or in combination to
build the joint for each target vessel.
Implantation technique
The implantation technique has been described extensively
in previous reports.9
Brieﬂy, all interventions were performed in a hybrid oper-
ating room under ﬂuoroscopic control (Axiom Artis FA;
SiemensMedical Solutions, Forchheim,Germany). All patients
underwent general anesthesia, and a totally percutaneous
approach using the Prostar XL 10 French vascular closure de-
vice (Abbott Vascular, Redwood City, CA, USA) was favored.
Surgical exposure of the left axillary artery was normally
used for the delivery and deployment of cuffs, while the
contralateral limb was generally preferred for fenestrations.
The AMB was deployed using a road mapping technique
and latterly, assisted by a three dimensional (3D) road
mapping tool (Siemens, Munich, Germany) using pre-
operative computer tomography angiography (CTA). Prior
to the introduction of the 3D road mapping, pre-
cannulation of the target vessels was done routinely.7 In
the case of AMB with cuffs only, the device was completely
deployed with restoration of limb perfusion prior to the
trans-axillary delivery of the BSGs. The aim of this maneuver
was to reduce ischemia, not only of both extremities, but
also of both hypogastric arteries. Considering that reposi-
tioning of the fenestrated graft remains essential for the
successful catheterization of the target vessels, this tech-
nique was not used with fenestrations.
It was always intended that placement of the AMB and
BSGs should be completed in a single stage. In order to
reduce the risk of spinal cord ischemia, staged approaches
were preferred for Crawford type II or III TAAAs.10 First, a
proximal endovascular thoracic aortic component was
implanted at the level of an adequate proximal landing zone,
and the AMB was delivered approximately 6e8 weeks later.
Surveillance protocol
Follow up clinical assessment, laboratory testing (including
evaluation of the glomerular ﬁltration rate [GFR]), and CTA
were obtained at 1 and 12 months, and annually thereafter.
In patients with renal impairment (GFR < 60 mL/minute/
1.73 m2), post-operative CT scans were performed using an
intra-arterial bolus of 30 mL contrast agent through a
Table 1. Patient demographics (n ¼ 150).
Mean  SD
Age (years) 70  8
Glomerular ﬁltration rate (mL/min/1.73 m2) 71.8  25.5
Body mass index 26.5  4.2
Maximum aortic diameter (mm) 63.6  12.6
Suprarenal aortic diameter (mm) 47.1  19.8
Aortic diameter at level of renals (mm) 37.9  15.6
Infrarenal aortic diameter (mm) 47.0  18.2
n (%)
Symptomatic 13 (8.7)
ASA IV 103 (68.7)
Smoking 86 (57.7)
Hypertension 139 (92.7)
Hyperlipidemia 89 (59.3)
Coronary artery disease 69 (46.0)
Chronic obstructive pulmonary disease 42 (28.0)
Previous aortic dissection 12 (8.0)
Diabetes mellitus 22 (14.7)
Dialysis 4 (2.7)
Note. ASA ¼ American Society of Anesthesiologists.
62 G. Panuccio et al.transbrachial angiographic catheter placed directly above
the most proximal part of the endograft.
Imaging was independently assessed using a dedicated
workstation (Aquarius Intuition) by the treating surgeon, a
radiologist, and a trained vascular surgeon (G.P.). Dedicated
multiple plain reconstructions, as well as BSG centerlines,
were performed to assess BSG related adverse events (i.e.,
stenosis, fracture, or endoleak).
Imaging outcomes reported in this article conform to the
reporting standards document for branched and fenes-
trated aneurysm repair,11 except for incomplete deﬁnitions
where the required modiﬁcations suggested by Mastracci
et al.,12 were used.
Outcome measures and deﬁnitions
The primary outcomes of this study were any re-
intervention due to BSG related complications (type 1 or
3 endoleak, dislocation, stenosis, and occlusion), any oc-
clusion, and the composite event of re-intervention and/or
occlusion (subsequently deﬁned as branch instability).
The following risk factors for the aforementioned out-
comes were evaluated: challenging target vessel, joint type
for BSG (cuffs vs. fenestrations), type of BSG (self vs. balloon
expandable), use of lining stent, need for multiple BSGs,
aneurysmal aorta at the visceral vessel level (TAAA Craw-
ford Type II or III), and renal artery as target vessel.
Secondary outcomes consisted of technical failure
(deﬁned as unsuccessful BSG deployment during the main
procedure), intra-operative vessel injuries (dissections and/
or perforations), and early target vessel occlusion.
Statistical analysis
Statistical analysis was performed with SPSS version 22.0
(IBM, Armonk, NY, USA).
A per vessel analysis in an intention to treat protocol was
done. In this model each single target vessel was analyzed
independently, so if a patient experienced different events
in different branches of the aneurysm; each was counted
separately.
Measured values were reported as percentages or
mean  SD. Fisher exact test and chi-square analysis were
used to correlate categorical variables with the peri-
operative outcome. Risk factors for the main measure
outcome were ﬁrst identiﬁed by univariate analysis and
then included in a multivariate analysis by means of logistic
regression model (backward method).
Actuarial survival analysis was performed using Kaplane
Meier life tables. Lines were truncated when the SE
exceeded 10%. The association of risk factors with primary
outcomes was determined by Cox regression analysis. For
each variable, log-linearity tests and proportional hazards
models were performed. p-Values of <.05 were considered
statistically signiﬁcant.
RESULTS
During the study period 263 patients were treated with f/
bEVAR at the authors’ institution. Among them, 150 (57%)consecutive patients were treated after 2010 and included
in this study. The mean  SD age of the study cohort was
70  8 years. Tables 1 and 2 summarize the patients and
aneurysm characteristics respectively. Solely fenestrated
stent grafts (three or four fenestrations) were ordered in 72
(48%) patients, and branched stent grafts in 68 (45%). The
remaining 10 (7%) patients were treated with endografts
having both branches and fenestrations.
One hundred twenty-four (83%) patients received a
custom made AMB and 26 (17%) an off the shelf bEVAR. All
AMBs were correctly and successfully (as planned) deployed
with the exception of one, where extreme kinking of the
aorta led to AMB dislocation during deployment.
Overall, 520 of 523 target vessels were revascularized (CT:
n ¼ 104 [20%]; SMA: n ¼ 140 [27%]; RRA: n ¼ 138 [27%];
LRA: n ¼ 134 [26%]; other vessels: n ¼ 4 [1%]). Technical
success was 99%.
All three failures (1%) were associated with a fenestration
as joint type for the renal vessel. Two kidneys could be
saveddone by a surgical iliac bypass and the other by a
periscope stent graft. In the third patient the planned sec-
ondary procedure could not be performed owing to his
bowel ischemia related death 40 days after the initial
intervention.
The mean procedure time was 266  71 minutes. Mean
ﬁuoroscopy time was 89  33 minutes, with a mean dose
area product 60,703  84,897 mGy/cm2. The mean amount
of contrast agent was 191  54 mL.Peri-operative vessel related events
The 30 day mortality was 3% (n ¼ 5). With the exception of
one patient with an unknown cause of death, there was no
relationship between 30 day mortality and BSG related
events (acute renal failure, n ¼ 1; cerebral bleeding with
herniation, n ¼ 1; pulmonary embolism, n ¼ 1; septic
shock, n ¼ 1).
Table 2. Aneurysm and device characteristics in 150 patients.
n %
I 7 4.7
II 27 18.0
Crawford classiﬁcation III 43 28.7
IV 44 29.3
Juxtarenal 29 19.3
Just branches 68 45.3
Main body type depending joint characteristic Just fenestrations 72 48.0
Both 10 6.7
Graft design CMD 124 82.7
Off the Shelf 26 17.3
1 4 2.7
2 9 6.0
Numbers of joints per main body 3 49 32.7
4 86 57.3
5 2 1.3
Note. CMD ¼ custom made design.
*Patients with aneurysmal aorta at visceral vessel level.
Performance of Bridging Stent Grafts 63During BSG insertion, four target vessels (1%) in four
different patients were injured (perforation, dissection, or
both) involving the renal artery in three (2%) and the SMA
in one (1%) (Table 3).
The renal artery as the target vessel showed a statistically
signiﬁcant association with peri-operative vessel related
events (nine of 266 [3%]; p ¼ .02). Of note, the use of a
relining stent also showed a trend towards signiﬁcance
(seven of 336 [2%]; p ¼ .06). Multivariate analysis
conﬁrmed the inﬂuence of the renal artery as the targetTable 3. Risk factors, and early and late vessel related events per typ
Target vessel type
CT
(n ¼ 104)
SMA
(n ¼ 140)
Risk factors n % n %
Challenging target vessel 29 27.9 6 4.
Joint type Fenestration 35 33.7 63 45.
Cuffs 69 66.3 77 55.
BSG type Balloon expandable 102 98.1 130 92.
Self expandable 2 1.9 10 7.
Relining 82 78.8 131 93.
Multiple BSG 29 27.9 21 15.
Peri-operative vessel related events
Complications 0 0.0 1 0.
Technical success 104 100.0 140 100.
BSG occlusions 0 0.0 0 0.
Combined 0 0.0 1 0.
Overall vessel related events
Re-interventions 4 3.8 4 2.
BSG occlusions 2 1.9 2 1.
BSG fracture 1 0.9 0 0.
BSG instability 6 5.8 6 4.vessel (odds ratio 13.2, 95% conﬁdence interval [CI] 1.5e
118.4; p ¼ .02) (Table 4).
An SMA dissection was identiﬁed by the onset of new
abdominal pain 6 days after the initial intervention. It was
localized at the end of the relining stent and was treated
with an extension of the stent. A second dissection was
at the level of the renal artery found in the post-
operative CTA. As a consequence of stable renal func-
tion and good perfusion, no further interventions were
done.e of target vessel.
RRA
(n ¼ 140)
LRA
(n ¼ 135)
Others
(n ¼ 4)
Total
(n ¼ 523)
n % n % n % n %
3 19 13.6 17 12.6 1 25.0 72 13.8
0 77 55.0 75 55.6 1 25.0 251 48.0
0 63 45.0 60 44.4 3 75.0 272 52.0
9 134 97.1 124 92.5 4 100.0 494 95.0
1 4 2.9 10 7.5 0 0.0 26 5.0
6 64 46.4 56 41.8 3 75.0 336 64.6
0 16 11.6 33 24.6 0 0.0 99 19.0
7 3 2.2 0 0.0 0 0.0 4 0.8
0 138 98.6 134 99.3 4 100.0 520 99.4
0 3 2.2 1 0.7 0 0.0 4 0.8
7 7 5.0 2 1.5 0 0.0 10 1.9
9 8 5.8 3 2.2 0 0.0 19 3.7
4 6 4.3 3 2.2 0 0.0 13 2.5
00 0 0.0 0 0.0 0 0.00 1 0.2
3 13 9.3 6 4.4 0 0.0 31 5.9
Table 4. Multivariate analysis of vessel related risk factors
associated with the peri-operative composite end point.a
OR 95% CI p
Challenging vessel 0.7 0.1e5.2 .69
Cuffs as joint type 0.5 0.1e4.0 .50
Self expandable BSG 0.0 0.0 1.00
Relining technique 3.3 0.4e27.1 .27
Multiple BSG 1.7 0.3e8.2 .54
TAAA Crawford type 2 or 3 1.6 0.3e7.4 .55
Renal artery as target vessel 13.2 1.5e118.4 .02
Note. OR ¼ odds ratio; CI ¼ conﬁdence interval; BSG ¼ bridging
stent graft; TAAA ¼ thoracoabdominal aortic aneurysms.
a Composite end point ¼ technical failure, vessel injuries, and
early occlusions.
64 G. Panuccio et al.Late vessel related events
The mean length of follow up was 15.0  12.6 months.
Patient compliance with follow up CTA imaging was 80% at
12 months (99 of 124), 87% at 24 months (33 of 38), and
68% at 36 months (15 of 22). The mean follow up interval
between two CTAs was 6  4 months, and two (1.3%)
patients were lost to follow up.
During the follow up period, 19 (4%) BSGs required a re-
intervention and there were 13 (2%) occlusions. Thirty oneMo
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Figure 1. KaplaneMeier curve for composite outcome over the follow
bridging stent graft (BSG).BSGs (n ¼ 31 [6%]) reached the composite end point. The 4
year freedom from secondary intervention and composite
event was 91% (SE 3%) and 79% (SE 6%), respectively. The 3
year freedom from occlusion was 85% (SE 6%). Univariate
analysis to determine factors associated with the secondary
intervention, occlusion, or composite event is illustrated in
Appendix 2. Cuffs as joint type showed a statistically signif-
icant association with secondary intervention (hazard ratio
[HR] 3.5, 95% CI 1.3e9.9; p ¼ .02) and for composite event
(HR 2.8, 95% CI 1.2e7.0; p < .01 [Fig. 1]) but not for oc-
clusion. No statistically signiﬁcant differences were recorded
between the different types of target vessel (Fig. 2).
In nine (1.7%) vessels, a crimping or collapse of the BSG
was observed, leading to ﬁve type 1b endoleaks, two ste-
noses and two vessel occlusions. A repeated percutaneous
transluminal angioplasty with the addition of a relining
stent was required to increase the wall adaptability at the
sealing zone (in case of endoleak), or at the level of the BSG
to restore the patency of the vessel (in case of stenosis). The
two occlusions were asymptomatic and were found during
the scheduled follow up CT and were not treated.
In two patients a disconnection of the BSG from the
fenestration led to a type 3 endoleak. In both cases, a
proximal extension of the BSG was successfully performed.nths of follow up
24 36 48
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Figure 2. KaplaneMeier curve for freedom from occlusion comparing different type of target vessel for bridging stent graft. Note.
CT ¼ celiac trunk; SMA ¼ superior mesenteric artery.
Performance of Bridging Stent Grafts 65An occlusion of the RRA was observed 7 months after the
operation with acute onset of ﬁank pain. The patient was
successfully treated by percutaneous thrombectomy with
the Rotarex thrombectomy system (Straub Medical,
Wangs, Switzerland). No BSG anomalies were found; how-
ever, this patient suffers from a thrombophilic disorder
caused by polycythemia vera. Based on the serum creati-
nine, no worsening of the renal function occurred.
Another renal artery occluded owing to a lateral move-
ment of the AMB and BSG, leading to malposition of its
distal end (Fig. 3).
In only one BSG was a fracture identiﬁed 21 months post-
procedure leading to a type 3 endoleak (Fig. 4). This was a
balloon expandable BSG deployed in a caudally directed cuff
with adjunctive lining stent. The CTA at 21 months showed a
fractured BSG in its mid-point probably related to longitudinal
and transverse movement of the AMB (6 mm based on the
centerline of ﬂow), and shrinkage of the aneurysm sac (vol-
ume difference 130 cm3).The patient was treated bymeans of
a supplementary balloon expandable BSG at the level of the
rupture. The ﬁnal angiogram showed no residual endoleak.
Finally, in ﬁve cases occlusion of the BSG was observed,
and no cause could be found. In two patients, SMA and CT
occlusion respectively were identiﬁed postmortem, and no
imaging was performed. The other two occlusions occurred
in both renal arteries in one patient; however, this patient
refused a CTA owing to the renal function impairment
(Table 5).DISCUSSION
This study focused on the midterm results of BSG and,
similar to other studies, an encouraging rate of freedom
from composite event of 80% at 3 years was found. How-
ever, in comparing the results with other reports, some
differences need to be highlighted. Mastracci et al., in
performing a per patient analysis, reported a freedom from
composite event rate of 89% at 3 years.12 However, in this
analysis, only one event per patient was documented and
interventions to BSGs were not taken into account sepa-
rately. This may bias the results considering that multiple
secondary procedures in each patient can underestimate
the rate of events. In contrast, in the current study the
focus was on the performance of each BSG, and a per
branch analysis on the basis of an intention to treat pro-
tocol was performed. In this way, each BSG and the related
factors and events could be analyzed independently. The
importance of this issue is reﬂected by the ﬁnding that 19
re-interventions for different BSGs occurred in 12 patients
(1.6 BSG related re-interventions per patient). Reilly et al.
also performed a per vessel analysis.13 They reported a
primary patency of 94.8% but this rate was not related to
time and cannot be compared with the patency rate in the
current study, which was based on KaplaneMeier analysis.
Another important aspect of this study is that the patient
outcomes during the last 4 years were analyzed exclusively.
This is important in order to minimize possible bias based
on the inﬂuence of the material evolution and of the
Figure 3. Occlusion of the left renal artery 1 year after the index procedure. (A) Multiplanar reconstruction passing through the centerline
of the branch (red lines). (B) Axial section. The circles highlight a calciﬁcation spot on the aneurysm wall. Over time, the shrinkage of the
aneurysm (6 mm; B) may induce a structural rearrangement of the aortic main body and its branches. In this case the angulations of the
branch for the left renal artery decreased, the lining stent (A, white arrows) does not follow the natural vessel curvature, going outside of
the vessel proﬁle (dashed lines) and probably inducing the occlusion.
66 G. Panuccio et al.learning curve. The experience of the authors of the current
study started in 2004, and in a previous evaluation it was
found that most of the adverse events were related to an
insufﬁcient landing zone or to imprecise planning of the
procedure.9 The main consequence was AMB migration
with related organ malperfusion. Therefore, a standardized
treatment protocol was introduced, including patient ex-
amination, indications, and planning. The interventions
were performed by the same surgical team, consisting of
doctors, nurses, and technicians. It is ﬁrmly believed by the
authors that, for a complex procedure like this, individualand team experience play an essential role. Like other ex-
periences, the number of vessels involved increased over
time (91.3% of the AMB included >3 branches) in order to
maximize the proximal landing zone (>2 cm length of
thrombus free aorta with minimal tortuosity).6,14
Several studies have reported the outcomes of both
fenestrated and cuffed devices or a combination of the
two.15e19 To the best of the authors’ knowledge there are
no studies to date analyzing the type of materials used as
risk factors for possible BSG related events. At present, a
great debate exists regarding the ideal joint, and a plethora
Figure 4. Fracture of the bridging stent graft (BSG) for the celiac trunk (CT) and associated type 3 endoleak 21 months after the ﬁrst
procedure (A, white arrow). (A) Migration of the aortic main body (6 mm based on centerline of ﬂow; C) may lead to collapse of a BSG,
especially when associated with shrinkage of the aneurysm (11 mm on axial reconstructions, B). Note. LSA ¼ left subclavian artery.
Performance of Bridging Stent Grafts 67of different solutions has been suggested. For example,
owing to the normal suprarenal aortic lumen, it is generally
accepted that fenestrated devices are typically preferred for
PAAs. However, Reilly et al. used an AMB containing four
internal/external cuffs, which was axially oriented and
caudally directed, in 23 patients, representing 28% of their
study cohort.13 In contrast, Mastracci et al. strongly suggest
fenestrations only for renal arteries,12 and they could not
ﬁnd any risk factor for branch instability. However, they
focused more on patient and aneurysm related risk factors
(demographic characteristics and aneurysm type) and not
on the inﬂuence of materials. In this context, it has already
been suggested that the performance of BSGs in terms of
patency rate and freedom from re-intervention is more
related to the material used.20
The current study found that BSG for the renal arteries
has a statistically increased rate of peri-operative events.
Compared with the SMA and CT, these vessels have a
smaller diameter and shorter length, and are more mobile
and tortuous. Reilly et al. also reported similar ﬁndings.13
However, in the long term, the type of target vessel no
longer represents a signiﬁcant risk factor. In the current
series, 12 events were related to the SMA and CT (5%), and
in two patients the SMA occlusions were established post-
mortem as cause of death. Of note, for the SMA, a relining
stent was used and no pathological ﬁndings were visible on
post-operative CTA imaging. Mastracci et al. initially re-
ported a similar rate of occlusions and re-interventions at
the level of the CT and SMA (n ¼ 33; 7%).12 Over the year
they started using a spiral side branch instead of fenestra-
tion, combined with a self expandable stent graft. Thisshould maximize the material overlapping, minimizing de-
vice tortuosity. Mastracci et al. reported no fracture and
suggested this design to overcome the problem.12 However,
other details regarding occlusions or the re-intervention
rate are missing, and a direct comparison is not possible.
Although directional cuffs should be conceptually supe-
rior to reinforced fenestrations in terms of joint durability, it
was found in the current study that they are more prone to
secondary procedures. This is probably explained by selec-
tion bias. In the authors’ institution, use of a directional cuff
was learned, especially for challenging cases, and this could
be responsible for the higher re-intervention rate. The au-
thors advocate fenestrated devices only when the AMB has
contact with the aortic wall and cuffed devices in a large
aortic visceral segment (the aortic diameter at the level of
the renal artery by cuff and fenestrated device was,
respectively, 41.9 mm and 34.4 mm; p < .01). The authors
also prefer a directed cuff in the presence of severe tortu-
osity of the access vessel. Precise deployment in the case of
a fenestrated AMB is mandatory, and imprecision can pre-
clude the revascularization of the visceral vessel. The only
three technical failures all occurred in cases of a fenestrated
device (1% vs. 0%; p ¼ .10). Larger and more tortuous
vessels are more prone to morphological remodeling,
resulting in a higher dynamic stress on the devices. In
contrast to the fenestrated joint, where the use of a balloon
expandable BSG is the only option, inside a cuff a self
expandable BSG has also been suggested for cuffed
endografts.18,21 Two different self expandable covered
stents are available at present (Appendix 1). However, the
low variability of length available, the less precise
Table 5. Summary of the cause of branch instability, the vessel involved, the correlation with computer tomography, and, if applicable, the associated re-intervention.
Note. BSG ¼ bridging stent graft; CT ¼ celiac trunk; SMA ¼ superior mesenteric artery; RRA ¼ right renal artery; LRA ¼ left renal artery; PTA ¼ percutaneous transluminal angioplasty.
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Performance of Bridging Stent Grafts 69deployment, and the poor visibility of the device are
important drawbacks of self expandable stent grafts. For
these reasons, balloon expandable BSGs were used in 92%
of cuffs in the current study. Moreover, by combining
multiple BSGs (in 75% of cases with cuff), exact deployment
in both landing zones (cuff and target vessel) was always
achieved.
By analyzing the causes leading to secondary procedures
or occlusions in the current study, it was observed that
crimping of the BSG was the most frequent source of
problems (n ¼ 9). In ﬁve BSGs, the sealing was lost at the
level of the target vessel. In the remaining BSGs (n ¼ 4)
kinking was associated with two stenoses and two occlu-
sions. In all cases, a balloon expandable BSG was used,
whereas ﬁve of them were relined with a self expandable
bare stent. The hypothesis is that the pinching load on the
BSG is related to the remodeling of the aorta and the vessel
pulsatility, which may induce a plastic deformation in the
long term. However, this scenario requires further investi-
gation. In the experience reported by Reilly et al.13 using
mostly self expandable BSGs, 11 occlusions and ﬁve BSG
stenoses (5%) were observed; none of them was related to
kinking or BSG collapse. No other occlusion mechanism was
suggested but, interestingly they encountered a higher rate
of vessel injuries (14 of 306; 5%) and two of them led to
occlusions. A possible source could be found in the stiffness
and higher radial forces as main characteristics of the self
expandable BSG leading to a modiﬁcation of the natural
target vessel anatomy, as also suggested by other authors.22
In this context, most authors agree that use of the relining
concept may stabilize the BSG, improve wall adaptability at
the sealing zone, and prevent kinking. However, neither
clinical nor in vitro studies have supported this concept.
Despite the extensive use of relining stents (64.6%),
plastic deformation remained the main reason for distal
type 1 endoleak and restenosis of the BSGs. Moreover, the
current study failed to conﬁrm the efﬁcacy of the relining
strategy. However, the indication for relining is based on
operator experience to obtain a better angiographic result
in challenging target vessel anatomy.
New balloon expandable BSGs have recently been made
available in Europe (Be graft; Bentley InnoMed, Hechingen,
Germany; E-ventus, Jotec, Hechingen, Germany). The stent
has a single layer expanded polytetraﬂuoroethylene mem-
brane covering, contributing to the higher ﬂexibility of the
device. Therefore, the stent can be used in tortuous renal
arteries without an additional relining stent (see Appendix 1).
To date, no stent related adverse events have been observed.
However, because of the limited experience, with a short
follow up, no comparison with other stents is possible.
The current study is not without limitations. The study
design lacks of randomization. No difference in comparing self
expandable and balloon expandable BSGs was found; how-
ever, in only 5% of the cases were self expandable stents used
(mainly for challenging target vessels). In conclusion, the pre-
sent study showed comparable and encouraging results of
different devices used as bridging stents. The mechanism
leading to occlusion seems to be different between balloonand self expandable stent grafts. Ballon expandable stent
grafts seem unable to follow aneurysm shrinkage and target
vessel movement during respiration. Self expandable stent
grafts may be more prone to damaging the vessel wall. A
dedicated device may improve the performance of bridging
stents, especially when combinedwith caudally directed cuffs.
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